SCHEMBL15026118

SCHEMBL15026118

CCOC(=O)c1cn(CCO[Si](C)(C)C(C)(C)C)nc1NC(=O)C(F)(F)F

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TRPM8 Q7Z2W7 1/20 0.41
▸ FOS P01100 4/20 0.37
▸ JUN P05412 4/20 0.37
▸ NFKB1 P19838 4/20 0.37
▸ NFKB2 Q00653 4/20 0.37
▸ RELA Q04206 4/20 0.37
▸ CYP3A4 P08684 1/20 0.37
▸ CYP2C19 P33261 1/20 0.37
▸ ADORA3 P0DMS8 5/20 0.33
▸ TEAD2 Q15562 1/20 0.33
▸ ADORA2A P29274 3/20 0.33
▸ ADORA1 P30542 3/20 0.33
▸ KDM4E B2RXH2 3/20 0.33
▸ ALDH1A1 P00352 2/20 0.33
▸ HTT P42858 1/20 0.33
▸ PDK1 Q15118 1/20 0.33
▸ PDK2 Q15119 1/20 0.33
▸ PDK3 Q15120 1/20 0.33
▸ PDK4 Q16654 1/20 0.33
▸ HSD17B10 Q99714 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15026115 0.86 KDM4E (0.38) FOSJUNNFKB1NFKB2RELA
SCHEMBL12429200 0.81 TRPM8 (0.40) TRPM8FOSJUNNFKB1NFKB2
SCHEMBL15026119 0.79 TEAD2 (0.39) CYP2C19ADORA3TEAD2ADORA2AADORA1
SCHEMBL15026117 0.79 TEAD2 (0.33) FOSJUNNFKB1NFKB2RELA
SCHEMBL18149668 0.72 FOS (0.38) FOSJUNNFKB1NFKB2RELA
SCHEMBL31714850 0.71 IKBKB (0.44) TEAD2KDM4EALDH1A1HTTHSD17B10
SCHEMBL13860366 0.70 L3MBTL1 (0.43) CYP3A4CYP2C19KDM4EALDH1A1HTT
SCHEMBL18131164 0.68 L3MBTL1 (0.36) KDM4EALDH1A1HTTNPC1RAB9A
SCHEMBL8696094 0.68 TEAD2 (0.38) TEAD2KDM4EALDH1A1HSD17B10HPGD
SCHEMBL8696070 0.67 LMNA (0.40) CYP2C19TEAD2KDM4EALDH1A1HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130150350-A1 Derivatives of 1-Phenyl-1,5-Dihydro-Benzo[B] [1,4]Diazepine-2,4-Dione as Inhibitors of HIV Replication BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2013-06-13 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130150350-A1 Derivatives of 1-Phenyl-1,5-Dihydro-Benzo[B] [1,4]Diazepine-2,4-Dione as Inhibitors of HIV Replication MED1, ZC3HAV1, BET1 TRPM8 4460/4885FOS 3262/4885JUN 933/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback